These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2933056)

  • 1. Degradation of factor VIII coagulant antigen by proteolytic enzymes.
    Rick ME; Popovsky MA; Krizek DM
    Br J Haematol; 1985 Nov; 61(3):477-86. PubMed ID: 2933056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of plasmin and protein Ca on factor VIII:C and VIII:CAg.
    Holmberg L; Ljung R; Nilsson IM
    Thromb Res; 1983 Jul; 31(1):41-50. PubMed ID: 6225218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the stability of factor VIII coagulant antigen (VIII:CAg) in the presence of VIII:C antibodies.
    Furlong RA; Peake IR
    Br J Haematol; 1983 Jan; 53(1):55-63. PubMed ID: 6401211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
    Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
    Weinstein MJ; Chute LE
    J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.
    Hellings JA; Over J; van Mourik JA
    Scand J Haematol; 1982 Nov; 29(5):353-62. PubMed ID: 6818685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified immunoradiometric assay for factor VIII coagulant antigen.
    Thomas KB; Howard MA; Koutts J; Firkin BG
    Br J Haematol; 1982 May; 51(1):47-57. PubMed ID: 6803825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification and functional significance of factor VIII components on normal platelets.
    Flaum MA; Donlon JA; Gralnick HR; Rick ME
    Thromb Res; 1982 May; 26(3):165-75. PubMed ID: 6810495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC).
    Tran TH; Lämmle B; Duckert F
    Am J Clin Pathol; 1984 Nov; 82(5):565-72. PubMed ID: 6437209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of autoantibodies to factor VIII: differences in specificity for apparently distinct antigenic determinants of factor VIII coagulant protein.
    Croissant MP; Zuzel M; Allain JP
    Blood; 1983 Jul; 62(1):133-40. PubMed ID: 6190519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic studies of factor VIII coagulant activity (VIII:C). 2. Factor VIII in selected vertebrates.
    Rotblat F; Hawkey C; O'Brien DP; Tuddenham EG
    Thromb Res; 1982 Mar; 25(5):423-31. PubMed ID: 6803390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of factor VIII coagulant antigen in normal, thrombin-treated, and hemophilic plasma.
    Weinstein M; Chute L; Deykin D
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5137-41. PubMed ID: 6795628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of low-molecular-weight canine factor VIII coagulant from von Willebrand plasma to canine factor VIII-related antigen.
    Benson RE; Johnson GS; Dodds WJ
    Br J Haematol; 1981 Dec; 49(4):541-50. PubMed ID: 6797460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
    Tran TH; Duckert F
    Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An enzyme immunoassay (ELISA) for the quantitation of human factor VIII coagulant antigen (VIII:CAg).
    Dinesen B; Feddersen C
    Thromb Res; 1983 Sep; 31(5):707-18. PubMed ID: 6417826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The separation of Willebrand factor from factor VIII-related antigen.
    Barrow ES; Reisner HM; Graham JB
    Br J Haematol; 1979 Jul; 42(3):455-68. PubMed ID: 314303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of factor VIII CAg by immunoradiometric assay in human tissue extracts.
    Exner T; Rickard KA; Kronenberg H
    Thromb Res; 1983 Nov; 32(4):427-36. PubMed ID: 6419382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of Factor VIII coagulant activity over Factor VIII coagulant antigen in diabetic children without vascular disease. A sign of activation of the Factor VIII coagulant moiety during poor diabetes control.
    Muntean WE; Borkenstein MH; Haas J
    Diabetes; 1985 Feb; 34(2):140-4. PubMed ID: 3917955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor.
    Switzer ME; Gordon HJ; McKee PA
    Biochemistry; 1983 Mar; 22(6):1437-44. PubMed ID: 6188490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.